The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

Vaccine Strategies in Follicular Lymphoma

Joshua Brody, MD
Published Online: 3:55 PM, Wed November 5, 2014
Joshua Brody, MD, assistant professor, Icahn School of Medicine, director, Lymphoma Immunotherapy Program, Mount Sinai Hospital, discusses vaccine strategies in follicular lymphoma. Brody presented on this topic at the 2014 Chemotherapy Foundation Symposium.

Clinical Pearls

  • First generations of lymphoma vaccines looked promising, but were not efficacious enough to become standard therapies.
  • New lymphoma vaccines take a more holistic perspective — targeting any tumor-specific or tumor-associated antigens.

<<< View more from the 2014 Chemotherapy Foundation Symposium

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.